Global Preclinical Evaluation and Certification Specialist Institution
The Biomaterial R&BD Center (BMC) is a leading institution established to support the entire development-to-commercialization process of bio-health-related products — one of the most promising future industries.
Through AAALAC International accreditation, BMC operates as a CRO-based preclinical testing center, offering services for new biomaterial-based medical devices (implants, tissue, bone, and dental applications) and veterinary medical devices.
To become a global leading biomaterial and medical-device preclinical evaluation center, providing world-class R&BD infrastructure, trusted regulatory support, and innovative translational research for the global bio-health industry.
Our Expertise
Preclinical Evaluation of Biomaterials and Medical Devices
Biocompatibility, safety, and performance assessment
Customized CRO Services
From study design to data analysis and reporting
Translational Research Collaboration
Bridging academic, clinical, and industrial R&D
Key Facilities
Major Equipment
